154 related articles for article (PubMed ID: 35815617)
61. Impact of intermittently scanned continuous glucose monitoring with alarms on sleep and metabolic outcomes in children and adolescents with type 1 diabetes.
Franceschi R; Scotton C; Leonardi L; Cauvin V; Maines E; Angriman M; Pertile R; Valent F; Soffiati M; Faraguna U
Acta Diabetol; 2022 Jul; 59(7):911-919. PubMed ID: 35397650
[TBL] [Abstract][Full Text] [Related]
62. Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes.
Guo L; Li Y; Zhang M; Xiao X; Kuang H; Yang T; Jia X; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1110845. PubMed ID: 36909344
[TBL] [Abstract][Full Text] [Related]
63. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden.
Jendle J; Buompensiere MI; Holm AL; de Portu S; Malkin SJP; Cohen O
Diabetes Ther; 2021 Nov; 12(11):2977-2991. PubMed ID: 34596879
[TBL] [Abstract][Full Text] [Related]
64. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
[TBL] [Abstract][Full Text] [Related]
65. Intermittently scanned continuous glucose monitoring is associated with lower spontaneous abortion rate compared with conventional blood glucose monitoring in pregnant women with type 1 diabetes: An observational study.
Lemaitre M; Faiz K; Baudoux F; Subtil D; Vambergue A
Diab Vasc Dis Res; 2022; 19(6):14791641221136837. PubMed ID: 36515497
[TBL] [Abstract][Full Text] [Related]
66. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World.
Cherubini V; Bonfanti R; Casertano A; De Nitto E; Iannilli A; Lombardo F; Maltoni G; Marigliano M; Bassi M; Minuto N; Mozzillo E; Rabbone I; Rapini N; Rigamonti A; Salzano G; Scaramuzza A; Schiaffini R; Tinti D; Toni S; Zagaroli L; Zucchini S; Maffeis C; Gesuita R
Diabetes Technol Ther; 2020 Jul; 22(7):509-515. PubMed ID: 32073311
[No Abstract] [Full Text] [Related]
67. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
Roze S; Smith-Palmer J; Valentine W; Payet V; de Portu S; Papo N; Cucherat M; Hanaire H
Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072
[TBL] [Abstract][Full Text] [Related]
68. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ; Griffin TP; Yap YW; Narendran P; Gallen G; Furlong N; Cranston I; Chakera A; Philbey C; Karamat MA; Saraf S; Kamaruddin S; Gurnell E; Chapman A; Hussain S; Elliott J; Leelarathna L; Ryder REJ; Hammond P; Lumb A; Choudhary P; Wilmot EG;
Diabetes Care; 2023 Oct; 46(10):1831-1838. PubMed ID: 37566697
[TBL] [Abstract][Full Text] [Related]
69. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
70. Comparison of an Intermittently Scanned (Flash) Continuous Glucose Monitoring System to Standard Self-Monitoring of Capillary Blood Glucose in Gestational Diabetes Mellitus.
Hussain FN; Raymond S; Feldman KM; Scarpelli-Shchur S; Strauss TS; Al-Ibraheemi Z; Brustman L
Am J Perinatol; 2023 Aug; 40(11):1149-1157. PubMed ID: 36918164
[TBL] [Abstract][Full Text] [Related]
71. Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes.
Sousa C; Neves JS; Dias CC; Sampaio R
Endocrine; 2023 Mar; 79(3):477-483. PubMed ID: 36574148
[TBL] [Abstract][Full Text] [Related]
72. Do-it-yourself continuous glucose monitoring in people aged 16 to 69 years with type 1 diabetes: A qualitative study.
Sehgal S; Boucsein A; Styles S; Palmer O; Paul RG; Crocket H; de Bock M; Wheeler BJ
Diabet Med; 2024 Feb; 41(2):e15168. PubMed ID: 37393600
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness, safety and costs of the FreeStyle Libre glucose monitoring system for children and adolescents with type 1 diabetes in Spain: a prospective, uncontrolled, pre-post study.
González-Pacheco H; Rivero-Santana A; Ramallo-Fariña Y; Valcárcel-Nazco C; Álvarez-Pérez Y; García-Pérez L; García-Bello MA; Perestelo-Pérez L; Serrano-Aguilar P;
BMJ Open; 2023 Dec; 13(12):e071334. PubMed ID: 38097245
[TBL] [Abstract][Full Text] [Related]
74. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
75. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
76. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project.
Ampudia-Blasco FJ; Ugarte-Abasolo E; Chico A; García-Alemán J; Galan-Barroso M
J Diabetes Sci Technol; 2023 Sep; 17(5):1256-1264. PubMed ID: 35466722
[TBL] [Abstract][Full Text] [Related]
77. IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial.
Aronson R; Brown RE; Chu L; Bajaj HS; Khandwala H; Abitbol A; Malakieh N; Goldenberg R
Diabetes Obes Metab; 2023 Apr; 25(4):1024-1031. PubMed ID: 36546594
[TBL] [Abstract][Full Text] [Related]
78. Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring.
Glocker V; Bachmann S; Hess M; Szinnai G; Burckhardt MA
Front Endocrinol (Lausanne); 2022; 13():958671. PubMed ID: 35966066
[TBL] [Abstract][Full Text] [Related]
79. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
[TBL] [Abstract][Full Text] [Related]
80. Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery.
Kim K; Choi SH; Jang HC; Park YS; Oh TJ
Diabetes Metab J; 2022 Sep; 46(5):713-721. PubMed ID: 35067012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
